BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10999819)

  • 1. Linear growth and final height after treatment for Cushing's disease in childhood.
    Lebrethon MC; Grossman AB; Afshar F; Plowman PN; Besser GM; Savage MO
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.
    Savage MO; Lienhardt A; Lebrethon MC; Johnston LB; Huebner A; Grossman AB; Afshar F; Plowman PN; Besser GM
    Horm Res; 2001; 55 Suppl 1():24-30. PubMed ID: 11408758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final adult height and body mass index after cure of paediatric Cushing's disease.
    Davies JH; Storr HL; Davies K; Monson JP; Besser GM; Afshar F; Plowman PN; Grossman AB; Savage MO
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):466-72. PubMed ID: 15807878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
    Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
    J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth in disorders of adrenal hyperfunction.
    Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
    Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G; Federico G; Barsanti S; Fiore L
    J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
    Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.
    Carroll PV; Monson JP; Grossman AB; Besser GM; Plowman PN; Afshar F; Savage MO
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):169-74. PubMed ID: 14725677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings.
    Coutant R; Rouleau S; Despert F; Magontier N; Loisel D; Limal JM
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M; Hochberg Z
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.